ATE524442T1 - Antiproliferative wirkstoffe - Google Patents

Antiproliferative wirkstoffe

Info

Publication number
ATE524442T1
ATE524442T1 AT02704961T AT02704961T ATE524442T1 AT E524442 T1 ATE524442 T1 AT E524442T1 AT 02704961 T AT02704961 T AT 02704961T AT 02704961 T AT02704961 T AT 02704961T AT E524442 T1 ATE524442 T1 AT E524442T1
Authority
AT
Austria
Prior art keywords
active ingredients
agents
antiproliferative active
certain
antiproliferative
Prior art date
Application number
AT02704961T
Other languages
English (en)
Inventor
Washington AYUKO
Michael Tisdale
Eric Lattmann
Original Assignee
Epx Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epx Res Ltd filed Critical Epx Res Ltd
Application granted granted Critical
Publication of ATE524442T1 publication Critical patent/ATE524442T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/88Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having the nitrogen atom of at least one of the carboxamide groups further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02704961T 2001-03-13 2002-03-12 Antiproliferative wirkstoffe ATE524442T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0106137A GB2373246B (en) 2001-03-13 2001-03-13 Antiproliferative agents
PCT/GB2002/001119 WO2002072553A1 (en) 2001-03-13 2002-03-12 Antiproliferative agents

Publications (1)

Publication Number Publication Date
ATE524442T1 true ATE524442T1 (de) 2011-09-15

Family

ID=9910551

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02704961T ATE524442T1 (de) 2001-03-13 2002-03-12 Antiproliferative wirkstoffe

Country Status (10)

Country Link
US (3) US6881846B2 (de)
EP (1) EP1377551B1 (de)
AT (1) ATE524442T1 (de)
AU (1) AU2002238760B2 (de)
BR (1) BR0208101A (de)
CA (1) CA2441001C (de)
GB (3) GB2402130B (de)
NZ (1) NZ528295A (de)
WO (1) WO2002072553A1 (de)
ZA (1) ZA200307067B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2730773A1 (en) 2008-07-14 2010-01-21 Martha Karen Newell Methods and products for treating proliferative diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4890982A (de) * 1972-03-06 1973-11-27
ZA846640B (en) * 1983-09-15 1985-04-24 Kendall & Co Microphase separated hydrogels for controlled release of bioactive materials
NL8701557A (nl) 1987-07-02 1989-02-01 Skf Ind Trading & Dev Werkwijze en inrichting voor het onderzoeken van slijtage- en wrijvingseigenschappen van loopvlakmaterialen bij glijdende wrijving.
JPH0672133B2 (ja) * 1987-12-28 1994-09-14 株式会社日本触媒 マレイミド類のアクリロニトリル溶液の輸送ならびに貯蔵方法
CA2018509A1 (en) * 1989-06-16 1990-12-16 Ryuichiro Tsumura Preparation process of n-substituted maleimides
JPH06100513A (ja) * 1992-09-25 1994-04-12 Nippon Shokubai Co Ltd マレインアミド酸エステルの製造方法

Also Published As

Publication number Publication date
BR0208101A (pt) 2004-03-02
US20050165066A1 (en) 2005-07-28
US7750181B2 (en) 2010-07-06
US7049338B2 (en) 2006-05-23
GB2373246B (en) 2005-03-02
US20050176779A1 (en) 2005-08-11
EP1377551A1 (de) 2004-01-07
GB0418552D0 (en) 2004-09-22
CA2441001A1 (en) 2002-09-19
GB2402129A (en) 2004-12-01
NZ528295A (en) 2005-08-26
GB2402130A (en) 2004-12-01
GB2402130B (en) 2005-10-26
EP1377551B1 (de) 2011-09-14
WO2002072553A1 (en) 2002-09-19
US6881846B2 (en) 2005-04-19
ZA200307067B (en) 2004-09-10
CA2441001C (en) 2012-08-21
GB0418553D0 (en) 2004-09-22
GB2373246A (en) 2002-09-18
GB2402129B (en) 2005-08-03
AU2002238760B2 (en) 2008-02-21
GB0106137D0 (en) 2001-05-02
US20040106648A1 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
CO5631443A2 (es) Derivados de 7-aril-3,9-diazabiciclo (3.3.1) non-6-eno y su uso como inhibidores de renina en el tratamiento de enfermedades de hipertension, cardiovasculares o renales
DE60214179D1 (de) IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN
ATE332301T1 (de) Antivirale pyrazolopyridin verbindungen
ATE301653T1 (de) Pyrazolopyridine
BRPI0418251C1 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
MXPA04012965A (es) Inhibidores virales.
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
BRPI0408251A (pt) compostos de pirazina como inibidores do fator de crescimento transformante (tgf)
ATE300541T1 (de) Pyrazolopyridinderivate
TW200510392A (en) Chemical compounds
GB0415365D0 (en) Pyrimidine derivatives
TW200505452A (en) Chemical compounds
ATE302203T1 (de) Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen
DK1448562T3 (da) Substituerede tetracycliske pyrroloquinolonderivater egnede som phosphodiesteraseinhibitorer
IL163608A (en) Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders
ATE274515T1 (de) Pyrazolopyridinderivate
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
ATE218560T1 (de) Wasserlösliche ähnliche verbindungen und medicament-vorstufe von paclitaxel
ATE524442T1 (de) Antiproliferative wirkstoffe
TW200628468A (en) Bicyclononene derivatives
DE60130009D1 (de) Makrolide
TW200621774A (en) Bicyclononene derivatives
HN2002000111A (es) Agentes antibacterianos
DE60309926D1 (de) Steroid-verbindungen mit anti-tumoraler wirkung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties